BTLA Antikörper
Kurzübersicht für BTLA Antikörper (ABIN610285)
Target
Alle BTLA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- CD272 on the cell surface of human PBMC in Flow cytometry, and to recombinant CD272-muIg in EIA.
-
Aufreinigung
- Protein A purified
-
Immunogen
-
Recombinant extracellular human CD272.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Approved: ELISA, Flo
Usage: ELISA: Capture. The applications listed have been tested for the unmodified form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 50 mM sodium phosphate, pH 7.5, 100 mM potassium chloride, 150 mM sodium chloride
-
Konservierungsmittel
- Azide free
-
Handhabung
- Do not freeze. Open under aseptic conditions.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 4°C. Do not freeze. Open under aseptic conditions.
-
-
-
: "Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells." in: The Journal of biological chemistry, Vol. 274, Issue 34, pp. 24059-65, (1999) (PubMed).
-
: "Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells." in: The Journal of biological chemistry, Vol. 274, Issue 34, pp. 24059-65, (1999) (PubMed).
-
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Andere Bezeichnung
- BTLA / CD272
-
Hintergrund
-
Name/Gene ID: BTLA
Synonyms: BTLA, BTLA1, B and T lymphocyte associated, CD272, B and T lymphocyte attenuator, B- and T-lymphocyte attenuator, CD272 antigen -
Gen-ID
- 151888
-
UniProt
- Q7Z6A9
-
Pathways
- Cancer Immune Checkpoints
Target
-